FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904347030> ?p ?o ?g. }

• W2904347030 endingPage "1424" @default.
• W2904347030 startingPage "1415" @default.
• W2904347030 abstract "Rheumatoid arthritis (RA) is a chronic, systemic, inflammatory disease causing symmetric polyarthritis. In this study, we aimed to investigate the effects of infliximab (INF) and methotrexate (MTX) on apoptosis, oxidative stress, and calcium signaling in the neutrophils of RA patients.Neutrophils were isolated from 10 patients with newly diagnosed RA and 10 healthy controls. They were divided into four groups (control, RA, RA + MTX, RA + INF) and incubated with MTX and INF. In the cell viability (MTT) test, the ideal non-toxic dose and incubation time of MTX were found to be 0.1 mM and 1 h, respectively. The neutrophils were also incubated with the TRPM2 channel blocker N-(p-amylcinnamoyl) anthranilic acid (ACA).Intracellular free Ca2+ concentration, intracellular reactive oxygen species (ROS) production, mitochondrial depolarization, lipid peroxidation, apoptosis, and caspase 3 and caspase 9 activities were found to be significantly higher in the neutrophils of RA patients compared to controls. MTT, reduced glutathione (GSH) level, and glutathione peroxidase (GSHPx) activity were significantly lower in the neutrophils of RA patients. However, MTT, GSH and GSHPx values were detected to be significantly increased with INF and MTX therapies. The Ca2+ concentrations were further decreased by the ACA therapy.Our results suggest that INF and MTX are useful antagonists in apoptosis and mitochondrial oxidative stress in the neutrophils of RA patients. INF and MTX decreased the Ca2+ concentration through inhibition of the TRPM2 channel in the neutrophils of RA patients. It may be a new pathway in the mechanisms of anti-rheumatic drugs." @default.
• W2904347030 created "2018-12-22" @default.
• W2904347030 creator A5015317989 @default.
• W2904347030 creator A5072496223 @default.
• W2904347030 creator A5087996145 @default.
• W2904347030 date "2019-01-01" @default.
• W2904347030 modified "2023-10-12" @default.
• W2904347030 title "Modulator role of infliximab and methotrexate through the transient receptor potential melastatin 2 (TRPM2) channel in neutrophils of patients with rheumatoid arthritis: a pilot study" @default.
• W2904347030 cites W1775749144 @default.
• W2904347030 cites W1803399375 @default.
• W2904347030 cites W180867511 @default.
• W2904347030 cites W1975980695 @default.
• W2904347030 cites W1982950563 @default.
• W2904347030 cites W1983425628 @default.
• W2904347030 cites W1987968975 @default.
• W2904347030 cites W1993359375 @default.
• W2904347030 cites W2000368283 @default.
• W2904347030 cites W2015309205 @default.
• W2904347030 cites W2016695100 @default.
• W2904347030 cites W2020377812 @default.
• W2904347030 cites W2027756656 @default.
• W2904347030 cites W2033753616 @default.
• W2904347030 cites W2034616899 @default.
• W2904347030 cites W2034866213 @default.
• W2904347030 cites W2048771152 @default.
• W2904347030 cites W2063576996 @default.
• W2904347030 cites W2068678184 @default.
• W2904347030 cites W2083608969 @default.
• W2904347030 cites W2085166560 @default.
• W2904347030 cites W2105746545 @default.
• W2904347030 cites W2109237866 @default.
• W2904347030 cites W2110827218 @default.
• W2904347030 cites W2128952811 @default.
• W2904347030 cites W2129867349 @default.
• W2904347030 cites W2136080760 @default.
• W2904347030 cites W2145301870 @default.
• W2904347030 cites W2146969934 @default.
• W2904347030 cites W2148707387 @default.
• W2904347030 cites W2167042220 @default.
• W2904347030 cites W2169768846 @default.
• W2904347030 cites W2234792878 @default.
• W2904347030 cites W2293073067 @default.
• W2904347030 cites W2301131921 @default.
• W2904347030 cites W2313462881 @default.
• W2904347030 cites W2320328374 @default.
• W2904347030 cites W2396288688 @default.
• W2904347030 cites W2400190003 @default.
• W2904347030 cites W2408962025 @default.
• W2904347030 cites W2414534734 @default.
• W2904347030 cites W2416322894 @default.
• W2904347030 cites W2515604782 @default.
• W2904347030 cites W2612079288 @default.
• W2904347030 cites W2742027271 @default.
• W2904347030 cites W2888026834 @default.
• W2904347030 cites W4211019157 @default.
• W2904347030 doi "https://doi.org/10.5114/aoms.2018.79485" @default.
• W2904347030 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6855169" @default.
• W2904347030 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31749869" @default.
• W2904347030 hasPublicationYear "2019" @default.
• W2904347030 type Work @default.
• W2904347030 sameAs 2904347030 @default.
• W2904347030 citedByCount "13" @default.
• W2904347030 countsByYear W29043470302020 @default.
• W2904347030 countsByYear W29043470302021 @default.
• W2904347030 countsByYear W29043470302022 @default.
• W2904347030 countsByYear W29043470302023 @default.
• W2904347030 crossrefType "journal-article" @default.
• W2904347030 hasAuthorship W2904347030A5015317989 @default.
• W2904347030 hasAuthorship W2904347030A5072496223 @default.
• W2904347030 hasAuthorship W2904347030A5087996145 @default.
• W2904347030 hasBestOaLocation W29043470301 @default.
• W2904347030 hasConcept C126322002 @default.
• W2904347030 hasConcept C151495721 @default.
• W2904347030 hasConcept C155164980 @default.
• W2904347030 hasConcept C170493617 @default.
• W2904347030 hasConcept C181199279 @default.
• W2904347030 hasConcept C185592680 @default.
• W2904347030 hasConcept C190283241 @default.
• W2904347030 hasConcept C203014093 @default.
• W2904347030 hasConcept C2776151105 @default.
• W2904347030 hasConcept C2777575956 @default.
• W2904347030 hasConcept C2779134260 @default.
• W2904347030 hasConcept C2779383735 @default.
• W2904347030 hasConcept C2780479503 @default.
• W2904347030 hasConcept C2780829032 @default.
• W2904347030 hasConcept C48349386 @default.
• W2904347030 hasConcept C538909803 @default.
• W2904347030 hasConcept C55493867 @default.
• W2904347030 hasConcept C71924100 @default.
• W2904347030 hasConcept C98274493 @default.
• W2904347030 hasConceptScore W2904347030C126322002 @default.
• W2904347030 hasConceptScore W2904347030C151495721 @default.
• W2904347030 hasConceptScore W2904347030C155164980 @default.
• W2904347030 hasConceptScore W2904347030C170493617 @default.
• W2904347030 hasConceptScore W2904347030C181199279 @default.
• W2904347030 hasConceptScore W2904347030C185592680 @default.
• W2904347030 hasConceptScore W2904347030C190283241 @default.
• W2904347030 hasConceptScore W2904347030C203014093 @default.

• next